Single-center multidisciplinary management of patients with colorectal cancer and resectable synchronous liver metastases improves outcomes.

[1]  C. Mariette,et al.  Management of patients with synchronous liver metastases of colorectal cancer. Clinical practice guidelines. Guidelines of the French society of gastrointestinal surgery (SFCD) and of the association of hepatobiliary surgery and liver transplantation (ACHBT). Short version. , 2011, Journal of visceral surgery.

[2]  Huiyan Zhu,et al.  Simultaneous vs. staged resection for synchronous colorectal liver metastases: a metaanalysis , 2011, International Journal of Colorectal Disease.

[3]  H. Kennecke,et al.  Patterns of Referral and Resection Among Patients with Liver-Only Metastatic Colorectal Cancer (MCRC) , 2010, Annals of Surgical Oncology.

[4]  L. Capussotti,et al.  Combined first‐stage hepatectomy and colorectal resection in a two‐stage hepatectomy strategy for bilobar synchronous liver metastases , 2010, The British journal of surgery.

[5]  S. Curley,et al.  Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? , 2010, Journal of the American College of Surgeons.

[6]  L. Viganò,et al.  Primary chemotherapy with or without colonic stent for management of irresectable stage IV colorectal cancer. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[7]  N. Kemeny,et al.  Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  B. Clary,et al.  Synchronous Colorectal Liver Metastases: Is It Time to Reconsider Traditional Paradigms of Management? , 2009, Annals of Surgical Oncology.

[9]  M. Ychou,et al.  Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  K. Slim,et al.  [Digestive oncology: surgical practices]. , 2009, Journal de chirurgie.

[11]  P. Wille-Jørgensen,et al.  Staged or simultaneous resection of synchronous liver metastases from colorectal cancer – a systematic review , 2009, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[12]  T. Ruers,et al.  Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  J. Tran van Nhieu,et al.  Chemotherapy Has Also an Effect on Primary Tumor in Colon Carcinoma , 2008, Annals of Surgical Oncology.

[14]  R. Adam,et al.  R1 Resection by Necessity for Colorectal Liver Metastases: Is It Still a Contraindication to Surgery? , 2008, Annals of surgery.

[15]  M. Gonen,et al.  Effect of Postoperative Morbidity on Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer , 2008, Annals of surgery.

[16]  Luca Viganò,et al.  Liver Surgery for Colorectal Metastases: Results after 10 Years of Follow-Up. Long-Term Survivors, Late Recurrences, and Prognostic Role of Morbidity , 2008, Annals of Surgical Oncology.

[17]  Thomas Gruenberger,et al.  Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial , 2008, The Lancet.

[18]  A. Neugut,et al.  Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review , 2008, International Journal of Colorectal Disease.

[19]  G. Maddern,et al.  Perioperative Morbidity Affects Long-Term Survival in Patients Following Liver Resection for Colorectal Metastases , 2008, Journal of Gastrointestinal Surgery.

[20]  W. Scheithauer,et al.  Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases , 2008, BMC Cancer.

[21]  M. Choti,et al.  Simultaneous Resections of Colorectal Cancer and Synchronous Liver Metastases: A Multi-institutional Analysis , 2007, Annals of Surgical Oncology.

[22]  J. Tran van Nhieu,et al.  Stents for palliation of obstructive metastatic colon cancer: impact on management and chemotherapy administration. , 2007, Archives of surgery.

[23]  T. Pawlik,et al.  Chemotherapy‐associated hepatotoxicity and surgery for colorectal liver metastases , 2007, The British journal of surgery.

[24]  U. Neumann,et al.  Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer , 2007, International Journal of Colorectal Disease.

[25]  R. Adam,et al.  Colorectal cancer with synchronous liver metastases , 2007, The British journal of surgery.

[26]  D. Ribero,et al.  Major Liver Resections Synchronous with Colorectal Surgery , 2006, Annals of Surgical Oncology.

[27]  Catherine Julié,et al.  Complete response of colorectal liver metastases after chemotherapy: does it mean cure? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  C. Lepage,et al.  Epidemiology and Management of Liver Metastases From Colorectal Cancer , 2006, Annals of surgery.

[29]  R. Parks,et al.  Guidelines for resection of colorectal cancer liver metastases , 2006, Gut.

[30]  O. Garden,et al.  Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies , 2006, British Journal of Cancer.

[31]  B. Nordlinger,et al.  Influence of Preoperative Chemotherapy on the Risk of Major Hepatectomy for Colorectal Liver Metastases , 2006, Annals of surgery.

[32]  O. Farges,et al.  The “50-50 Criteria” on Postoperative Day 5: An Accurate Predictor of Liver Failure and Death After Hepatectomy , 2005, Annals of surgery.

[33]  F. Lévi,et al.  Tumor Progression While on Chemotherapy: A Contraindication to Liver Resection for Multiple Colorectal Metastases? , 2004, Annals of surgery.

[34]  S. Sebastian,et al.  Pooled Analysis of the Efficacy and Safety of Self-Expanding Metal Stenting in Malignant Colorectal Obstruction , 2004, American Journal of Gastroenterology.

[35]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[36]  F. Lévi,et al.  Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver , 2003, The British journal of surgery.

[37]  F. Brunetti,et al.  Anatomical Bi- and Trisegmentectomies as Alternatives to Extensive Liver Resections , 2003, Annals of surgery.

[38]  M. Ychou,et al.  [Therapeutic management of hepatic metastases from colorectal cancers]. , 2003, Gastroenterologie clinique et biologique.

[39]  W. Jarnagin,et al.  Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases , 2003, Journal of Gastrointestinal Surgery.

[40]  L H Blumgart,et al.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.

[41]  F. Brunetti,et al.  Hepatic vascular exclusion with preservation of the caval flow for liver resections. , 1999, Annals of surgery.